Insulin, Aspart, Human

Known as: Insulin X14, Aspart, B28-Aspart-Insulin 
A recombinant human insulin analog with rapid-acting, blood glucose-lowering activity. Insulin aspart, acting faster than regular human insulin… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BACKGROUND Basal insulin therapy does not stop loss of β-cell function, which is the hallmark of type 2 diabetes mellitus, and… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The aim of this cohort study was to investigate the risk of malignant neoplasms and mortality in patients with diabetes treated… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE The objective of the study was a comparison of insulin aspart (IAsp) with human insulin (HI) in basal-bolus therapy… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To assess the safety and efficacy of insulin aspart (IAsp) versus regular human insulin (HI) in basal-bolus therapy… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
AIM The aim of this study was to compare the efficacy and safety of a basal-bolus insulin regimen comprising either insulin… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Highly Cited
2004
OBJECTIVE The efficacy of the insulin analogs now available for multiple daily injection (MDI) and continuous subcutaneous… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE Insulin detemir is a soluble basal insulin analog with a unique mechanism of protracted action designed to reduce the… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
In recent years, analogs of human insulin have been engineered with the aim of improving therapy for people with diabetes. To… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?